Meet our team

Aclipse management team has extensive experience in drug development including nonclinical and clinical development, regulatory manufacturing, and drug product introductions. Our team has a strong proven track record in business development, including in- and out-licensing, acquisitions, and collaborations. Aclipse management team members recently exited Thar Pharmaceuticals (acquired by Grünenthal GmbH) and Lev Pharmaceuticals (now Takeda).

Dame Pamela J Shaw,
DBE MD

Chairman of the
Clinical Advisory Board

Merit E Cudkowicz, MD

Clinical Advisor

Hiroshi Mitsumoto, MD

Clinical Advisor

Leonard H. van den Berg,
MD PhD

Clinical Advisor

Orla Hardiman, MD

Clinical Advisor
We're here to answer any questions.
Looking to connect with us?